| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.007 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |